” Biogen plans to cut about 11 percent of its workforce as it refocuses its research on treatments for Azheimer’s disease and multiple sclerosis. The company announced the job cuts Wednesday as boosted its profit outlook and it reported a 12.7 percent jump in third-quarter earnings to $965.6 million, or $4.15 per share.
Are you up for a challenge?
